American company Vektor Medical has received the prestigious CE mark for its non-invasive cardiac arrhythmia mapping system, vMap. This allows them to plan their expansion into the European Union and use artificial intelligence to diagnose heart arrhythmias.
Scientists have managed to engineer viruses that can infect only specific bacteria. This discovery opens up vast opportunities for medical innovation through new forms of therapy — but it also raises serious concerns about potential misuse, including the development of biological weapons.
Dutch firm Pharming Group has announced that its workforce reduction plan is progressing as scheduled. Up to 20% of non-medical staff could lose their jobs — mainly those based at the company’s headquarters. The goal is to boost operational efficiency and achieve profitability more quickly.
Pharmaceutical giant AstraZeneca is betting on AI. The company has just signed a deal worth up to $555 million with U.S.-based startup Algen Biotechnologies. The partnership aims to advance therapies that combine gene editing with artificial intelligence.